Compare Glenmark Pharma with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA PROCTER & GAMBLE HEALTH GLENMARK PHARMA/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 12.9 48.9 26.5% View Chart
P/BV x 2.0 12.1 16.2% View Chart
Dividend Yield % 0.5 2.6 20.1%  

Financials

 GLENMARK PHARMA   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-21
PROCTER & GAMBLE HEALTH
Jun-21
GLENMARK PHARMA/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs5737,500 7.6%   
Low Rs1954,004 4.9%   
Sales per share (Unadj.) Rs387.8607.7 63.8%  
Earnings per share (Unadj.) Rs34.4106.5 32.3%  
Cash flow per share (Unadj.) Rs50.1124.6 40.2%  
Dividends per share (Unadj.) Rs2.50130.00 1.9%  
Avg Dividend yield %0.72.3 28.8%  
Book value per share (Unadj.) Rs249.6421.6 59.2%  
Shares outstanding (eoy) m282.1716.60 1,699.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.09.5 10.5%   
Avg P/E ratio x11.254.0 20.7%  
P/CF ratio (eoy) x7.746.2 16.6%  
Price / Book Value ratio x1.513.6 11.3%  
Dividend payout %7.3122.1 6.0%   
Avg Mkt Cap Rs m108,35395,477 113.5%   
No. of employees `000NANA-   
Total wages/salary Rs m23,4371,505 1,557.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m109,43910,087 1,084.9%  
Other income Rs m502181 277.4%   
Total revenues Rs m109,94110,268 1,070.7%   
Gross profit Rs m21,2892,460 865.3%  
Depreciation Rs m4,436300 1,476.5%   
Interest Rs m3,5318 44,139.1%   
Profit before tax Rs m13,8252,333 592.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,124565 730.1%   
Profit after tax Rs m9,7011,768 548.7%  
Gross profit margin %19.524.4 79.8%  
Effective tax rate %29.824.2 123.2%   
Net profit margin %8.917.5 50.6%  
BALANCE SHEET DATA
Current assets Rs m73,59610,389 708.4%   
Current liabilities Rs m42,0105,507 762.9%   
Net working cap to sales %28.948.4 59.6%  
Current ratio x1.81.9 92.9%  
Inventory Days Days7289 2.3%  
Debtors Days Days86215 39.9%  
Net fixed assets Rs m67,0939,390 714.5%   
Share capital Rs m282166 170.0%   
"Free" reserves Rs m70,1486,832 1,026.7%   
Net worth Rs m70,4306,998 1,006.4%   
Long term debt Rs m38,8880-   
Total assets Rs m140,68919,778 711.3%  
Interest coverage x4.9292.6 1.7%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.80.5 152.5%   
Return on assets %9.49.0 104.7%  
Return on equity %13.825.3 54.5%  
Return on capital %15.933.4 47.5%  
Exports to sales %00-   
Imports to sales %014.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA1,462 0.0%   
Fx inflow Rs m35,7531,331 2,685.7%   
Fx outflow Rs m12,0231,462 822.3%   
Net fx Rs m23,729-131 -18,114.1%   
CASH FLOW
From Operations Rs m11,3122,473 457.5%  
From Investments Rs m-6,752-323 2,092.5%  
From Financial Activity Rs m-4,418-3,866 114.3%  
Net Cashflow Rs m278-1,716 -16.2%  

Share Holding

Indian Promoters % 46.7 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 35.0 14.5 241.7%  
FIIs % 24.2 6.0 405.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.4 48.2 110.7%  
Shareholders   317,383 65,537 484.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Indian Indices End Flat Amid High Volatility; Maruti Suzuki & Tech Mahindra Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views on News

GLENMARK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of GLENMARK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY22); Net Profit Up 20.7% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 20.7% YoY). Sales on the other hand came in at Rs 30 bn (up 26.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

Top Indian Drone Companies to Watch Out for in 2022(Views On News)

Jan 21, 2022

Several companies are adopting drone technology for regular business operations.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Jan 28, 2022 (Close)

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA 8-QTR ANALYSIS

COMPARE GLENMARK PHARMA WITH

MARKET STATS